Homology Medicines, Inc. – NASDAQ:FIXX
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 12 hours
Homology Medicines stock price monthly change
+16.38%
month
Homology Medicines stock price quarterly change
-31.29%
quarter
Homology Medicines stock price yearly change
-50.60%
year
Homology Medicines key metrics
Market Cap | 3.01M |
Enterprise value | 52.81M |
P/E | -11.1 |
EV/Sales | 16.46 |
EV/EBITDA | -16.06 |
Price/Sales | 17.86 |
Price/Book | 0.32 |
PEG ratio | -0.11 |
EPS | -260.65 |
Revenue | N/A |
EBITDA | -85.85M |
Income | -83.08M |
Revenue Q/Q | -100% |
Revenue Y/Y | -44.76% |
Profit margin | -156.02% |
Oper. margin | -4154.64% |
Gross margin | 0% |
EBIT margin | -4154.64% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHomology Medicines stock price history
Homology Medicines stock forecast
Homology Medicines financial statements
| Jun 2023 | 354K | -35.04M | -9899.44% |
|---|---|---|---|
| Sep 2023 | 0 | -32.95M | |
| Dec 2023 | 1.41M | -16.11M | -1136.74% |
| Mar 2024 | 0 | 1.02M |
| 2027 | 2M | -311.66K | -15.58% |
|---|
Analysts Price target
Financials & Ratios estimates
| 2024-05-09 | -0.23 | -0.5 |
|---|
| Jun 2023 | 169337000 | 49.96M | 29.5% |
|---|---|---|---|
| Sep 2023 | 140063000 | 51.85M | 37.02% |
| Dec 2023 | 306119000 | 233.12M | 76.16% |
| Mar 2024 | 152334000 | 103.56M | 67.99% |
| Jun 2023 | -23.66M | 61.00M | 2K |
|---|---|---|---|
| Sep 2023 | -24.94M | -22.76M | 18K |
| Dec 2023 | -21.57M | 31.71M | 14K |
| Mar 2024 | -14.55M | 97K | 99.34M |
Homology Medicines alternative data
| Aug 2023 | 92 |
|---|---|
| Sep 2023 | 92 |
| Oct 2023 | 92 |
| Nov 2023 | 92 |
| Dec 2023 | 92 |
| Jan 2024 | 92 |
| Feb 2024 | 92 |
| Mar 2024 | 7 |
| Apr 2024 | 7 |
| May 2024 | 7 |
| Jun 2024 | 7 |
| Jul 2024 | 7 |
Homology Medicines other data
16.68%
-20.06%
of FIXX is owned by hedge funds
40
-36
9.57M
-11.53M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2023 | 0 | 10965 |
| Aug 2023 | 0 | 1952 |
| Sep 2023 | 0 | 1448 |
| Jan 2024 | 0 | 8988 |
| Insider | Compensation |
|---|---|
| Dr. Arthur O. Tzianabos Ph.D. (1963) Pres, Chief Executive Officer & Director | $885,960 |
| Dr. Albert Seymour Ph.D. (1968) Chief Scientific Officer | $607,580 |
Mr. W. Bradford Smith CPA, M.B.A. (1956) Chief Financial Officer & Treasurer | $582,380 |
-
When is Homology Medicines's next earnings date?
Unfortunately, Homology Medicines's (FIXX) next earnings date is currently unknown.
-
Does Homology Medicines pay dividends?
No, Homology Medicines does not pay dividends.
-
How much money does Homology Medicines make?
Homology Medicines has a market capitalization of 3.01M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 63.97% to 1.16M US dollars. Homology Medicines made a loss 112.96M US dollars in net income (profit) last year or -$0.5 on an earnings per share basis.
-
What is Homology Medicines's stock symbol?
Homology Medicines, Inc. is traded on the NASDAQ under the ticker symbol "FIXX".
-
What is Homology Medicines's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Homology Medicines?
Shares of Homology Medicines can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Homology Medicines's key executives?
Homology Medicines's management team includes the following people:
- Dr. Arthur O. Tzianabos Ph.D. Pres, Chief Executive Officer & Director(age: 62, pay: $885,960)
- Dr. Albert Seymour Ph.D. Chief Scientific Officer(age: 57, pay: $607,580)
- Mr. W. Bradford Smith CPA, M.B.A. Chief Financial Officer & Treasurer(age: 69, pay: $582,380)
-
How many employees does Homology Medicines have?
As Jul 2024, Homology Medicines employs 7 workers.
-
When Homology Medicines went public?
Homology Medicines, Inc. is publicly traded company for more then 7 years since IPO on 28 Mar 2018.
-
What is Homology Medicines's official website?
The official website for Homology Medicines is homologymedicines.com.
-
Where are Homology Medicines's headquarters?
Homology Medicines is headquartered at One Patriots Park, Bedford, MA.
-
How can i contact Homology Medicines?
Homology Medicines's mailing address is One Patriots Park, Bedford, MA and company can be reached via phone at +7 813017277.
Homology Medicines company profile:
Homology Medicines, Inc.
homologymedicines.comExchange:
NASDAQ
Full time employees:
7
Industry:
Biotechnology
Sector:
Healthcare
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
One Patriots Park
Bedford, MA 01730
Bedford, MA 01730
CIK: 0001661998
ISIN: US4380831077
CUSIP: 438083107
